Literature DB >> 18032735

Spontaneous atherosclerosis in aged lipoprotein lipase-deficient mice with severe hypertriglyceridemia on a normal chow diet.

Xiaohong Zhang1, Rong Qi, Xunde Xian, Fei Yang, Michael Blackstein, Xuming Deng, Jianglin Fan, Colin Ross, Joanna Karasinska, Michael R Hayden, George Liu.   

Abstract

Large-scale epidemiological studies have revealed a strong association between hypertriglyceridemia and coronary arteriosclerotic disease. However, there are conflicting reports whether the severe hypertriglyceridemia caused by lipoprotein lipase (LPL) deficiency is pro- or antiatherogenic. To determine the effect of LPL deficiency on atherosclerosis, we pursued long-term observation of the development of atherosclerotic lesions in an LPL gene deficient mouse model. At 4 months of age, homozygous LPL-deficient mice exhibited severe hypertriglyceridemia but no signs of aortic atherosclerotic lesions. At >15 months of age, these mice developed foam cell-rich atherosclerotic lesions at the aortic root, whereas wild-type and heterozygous mice were lesion-free at the same age. Further investigation revealed that plasma malondialdehyde levels in >15-month-old LPL-deficient mice were significantly higher than those of heterozygous and wild-type mice. Electron spin resonance analysis showed a marked increase in oxidative susceptibility of chylomicrons from the aged LPL-deficient mice. Incubation of chylomicrons from >15-month-old LPL-deficient mice with cultured human umbilical vein endothelial cells showed significantly increased upregulation of vascular cell adhesion molecule-1 and monocyte chemoattractant protein-1, markers of enhanced endothelial activation, and enhanced adherence of human THP-1 mononuclear cells. These results clearly demonstrate the occurrence of spontaneous atherosclerosis in aged LPL-deficient mice mediated by the oxidation of chylomicrons and the activation of vascular endothelial cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18032735     DOI: 10.1161/CIRCRESAHA.107.156554

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  31 in total

1.  Regulating intestinal function to reduce atherogenic lipoproteins.

Authors:  M Mahmood Hussain; Tung Ming Leung; Liye Zhou; Sarah Abu-Merhi
Journal:  Clin Lipidol       Date:  2013-08-01

Review 2.  Glycosylphosphatidylinositol-anchored high-density lipoprotein-binding protein 1 and the intravascular processing of triglyceride-rich lipoproteins.

Authors:  O Adeyo; C N Goulbourne; A Bensadoun; A P Beigneux; L G Fong; S G Young
Journal:  J Intern Med       Date:  2012-11-01       Impact factor: 8.989

3.  Cholesterol intake modulates plasma triglyceride levels in glycosylphosphatidylinositol HDL-binding protein 1-deficient mice.

Authors:  Michael M Weinstein; Yiping Tu; Anne P Beigneux; Brandon S J Davies; Peter Gin; Constance Voss; Rosemary L Walzem; Karen Reue; Peter Tontonoz; André Bensadoun; Loren G Fong; Stephen G Young
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-09-02       Impact factor: 8.311

Review 4.  The metabolism of triglyceride-rich lipoproteins revisited: new players, new insight.

Authors:  Geesje M Dallinga-Thie; Remco Franssen; Hans L Mooij; Maartje E Visser; H Carlijne Hassing; Frank Peelman; John J P Kastelein; Miklós Péterfy; Max Nieuwdorp
Journal:  Atherosclerosis       Date:  2009-12-29       Impact factor: 5.162

5.  Rutaecarpine suppresses atherosclerosis in ApoE-/- mice through upregulating ABCA1 and SR-BI within RCT.

Authors:  Yanni Xu; Qi Liu; Yang Xu; Chang Liu; Xiao Wang; Xiaobo He; Ningyu Zhu; Jikai Liu; Yexiang Wu; Yongzhen Li; Ni Li; Tingting Feng; Fangfang Lai; Murui Zhang; Bin Hong; Jian-Dong Jiang; Shuyi Si
Journal:  J Lipid Res       Date:  2014-06-07       Impact factor: 5.922

Review 6.  Biochemistry and pathophysiology of intravascular and intracellular lipolysis.

Authors:  Stephen G Young; Rudolf Zechner
Journal:  Genes Dev       Date:  2013-03-01       Impact factor: 11.361

Review 7.  Evaluation and treatment of hypertriglyceridemia: an Endocrine Society clinical practice guideline.

Authors:  Lars Berglund; John D Brunzell; Anne C Goldberg; Ira J Goldberg; Frank Sacks; Mohammad Hassan Murad; Anton F H Stalenhoef
Journal:  J Clin Endocrinol Metab       Date:  2012-09       Impact factor: 5.958

8.  The role of caveolin-1 and syndecan-4 in the internalization of PEGylated PAMAM dendrimer polyplexes into myoblast and hepatic cells.

Authors:  Wenwen Shen; Mallory A van Dongen; Yingchun Han; Maomao Yu; Yanzhi Li; George Liu; Mark M Banaszak Holl; Rong Qi
Journal:  Eur J Pharm Biopharm       Date:  2014-07-30       Impact factor: 5.571

9.  Effects of two therapeutic dietary regimens on primary chylomicronemia in paediatric age: a retrospective data analysis.

Authors:  O Helk; R Schreiber; K Widhalm
Journal:  Eur J Clin Nutr       Date:  2016-05-18       Impact factor: 4.016

10.  The 5-lipoxygenase as a common pathway for pathological brain and vascular aging.

Authors:  Jin Chu; Domenico Praticò
Journal:  Cardiovasc Psychiatry Neurol       Date:  2009-09-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.